Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : GlaxoSmithKline
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development Ltd
MAJ Il y a 4 ans
An open-label, non-randomized pharmacokinetic and safety study of repeat doses of fluticasone furoate and GW642444M combination in healthy subjects and in subjects with severe renal impairment
• To investigate the effect of severe renal impairment on the pharmacokinetics of FF and GW642444 following repeat administration of FF/ GW642444M (200/25mcg)via NDPI
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline AB
MAJ Il y a 4 ans
Follow-up survey for comparing stable dosing with a symptom based “as needed-regimen” in moderate and severe persitent asthma
The main objective of the trial is to exemplify in detail the control or lack of control of asthma based on two different regimens. The two regimens are; regular treatment using stable dosing of Seret...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline R&D Ltd
MAJ Il y a 4 ans
A 24-week, double-blind, double-dummy, randomized, parallel-group study to investigate the effects of rosiglitazone (extended release tablets), donepezil, and placebo as monotherapy on cognition and overall clinical response in APOE ε4-stratified subjects with mild to moderate Alzheimer’s disease. (REFLECT-1)
•To investigate the effects of daily dosing for 24 weeks with RSG XR versus placebo on cognitive function in subjects with mild to moderate Alzheimer’s disease as a function of APOE ε4 status. •To in...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research & Development
MAJ Il y a 4 ans
A Phase IIb, 12-week, multicenter, randomized, double-blind, placebo-controlled, pioglitazone-controlled, parallel-group dose-ranging study in approximately 336 male and female subjects, aged 18 to 70 years with type 2 diabetes mellitus who are treatment naïve
The present study is a dose-ranging study that will evaluate the efficacy, safety and tolerability of a range of doses of GSK189075 and pioglitazone 30mg, compared to placebo, administered as monother...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Consumer Healthcare
MAJ Il y a 4 ans
The Effects of Weight Reduction with Orlistat vs. Placebo on Changes in Body Composition
To determine whether a 24 week weight loss program with orlistat will produce a greater reduction from baseline in abdominal visceral adipose tissue (VAT) mass compared to placebo in overweight and cl...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research and Development Ltd
MAJ Il y a 4 ans
A study to test two investigational drugs, dabrafenib and trametinib, for treating melanoma
To establish the superiority of dabrafenib and trametinib combination therapy over dabrafenib and trametinib placebo (dabrafenib monotherapy) with respect to progression-free survival (PFS) for subjec...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline, S.A
MAJ Il y a 4 ans
An Eight-Week, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Efficacy and Safety of Talnetant in Subjects with Irritable Bowel Syndrome
The primary objective is to determine whether talnetant provides adequate relief of IBS pain and discomfort in any dose group compared to placebo and to determine the safety and tolerability in IBS su...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline AB
MAJ Il y a 4 ans
Seretide vs Flixotide in mild persistent asthma (GINAII)
The main objective of the study is to compare Seretide Diskus with Flutide Diskus in controlling mild persistent asthma. The protocol allow an increase in treatment during the first six months of the ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Research and Development Limited
MAJ Il y a 4 ans
A randomized, double-blind, placebo-controlled phase III study, to evaluate the efficacy, safety and tolerability of eltrombopag olamine (SB-497115-GR), a thrombopoietin receptor agonist, administered for 6 months as oral tablets once daily in adult subjects with previously treated chronic idiopathic thrombocytopenic purpura (ITP)
To determine the efficacy of oral eltrombopag, when administered once daily, for 6 months duration, to previously treated adult subjects with chronic ITP
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Pharma A/S
MAJ Il y a 4 ans
A randomized, open label comparative study to determine the proportion of asthma patients on Seretide Diskus 50/250 mcg b.i.d. achieving total control when given medication and compli-ance enhancement training compared to those receiving medica-tion only
To determine the proportion of asthma subjects achieving Total control of their asthma in 7 weeks out of the last 8 consecutive weeks of treatment period 2 when given Seretide Diskus 50/250 mcg b.i.d ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
5
6
7
8
9
10
11
12
13
14
Suivant